RTX · RTX Corp
Price & Indicators
Up next
Metrics snapshot
Useful current figures from the complete screener profile.
Equibles Research
our published analysis of this company-
Research ThesisSpaceX's $1.8T cap is a two-customer AI bet, with $14.1B in CSAs carrying the entire $100B ARR claim
A Q2-print read on SpaceX as a public company: how $15.8B of the $18.4B Q2 capex flowed into the AI segment, why Customer B at 19.5% and Customer A at 18.3% of revenue sit between the $47.5B backlog and the $100B December ARR target, and how the Cursor close reframes the same concentration risk.
-
Research ThesisRocket Lab's $2.2B backlog makes the bull case bigger than Neutron
Rocket Lab's record Q1 and $2.2B backlog show the bull case no longer rests on Neutron alone. The proposed Iridium merger could add a recurring-services engine, while financing, dilution and execution remain the price of that upside.
-
Research ThesisRocket Lab: Backlog is converting, but the $39B market cap is paying for a Neutron debut the company has yet to validate
Rocket Lab enters Q2 2026 with record backlog of $2,219.8M and guided revenue of $225.0M–$240.0M, yet the stock trades at -55.2% from its $150.23 high on a $39.0B market cap against $679.6M of trailing revenue — a gap the equity-funded growth model and the un-flown Neutron debut have to close.
Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders SellIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Company-funded Research and Development | $726M | Quarter Ended June 30, 2026 filing | — |
| Customer-funded Research and Development | $1.28B | Quarter Ended June 30, 2026 filing | — |
| Organic change in Cost of sales non-GAAP | $2.72B | Quarter Ended June 30, 2026 filing | — |
| Organic change in Net sales non-GAAP | $3.51B | Quarter Ended June 30, 2026 filing | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Aerospace & Defense — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
RTX
this stock
RTX Corp
|
$255.27B | +1.9% | +17.1% | 33.4 | 1.0% |
|
SPCX
Space Exploration Technologies Corp
|
$1.96T | — | — | — | 1.2% |
|
GE
General Electric Co
|
$339.38B | +3.2% | +18.5% | 38.5 | 1.5% |
|
EADSF
Airbus SE/ADR
|
$174.13B | -5.1% | — | — | 0.1% |
|
BA
Boeing Co
|
$148.34B | -13.6% | +34.5% | 67.5 | 1.8% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| RTX | -2.1% | -10.0% | -8.1% | -10.0% | +1.9% |
| SPY | -1.2% | -0.4% | +13.1% | -0.4% | +12.1% |
| vs SPY | -0.9% | -9.6% | -21.2% | -9.6% | -10.1% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.